Mera Pharmaceuticals, Inc.
MRPI
$0.00
$0.000.00%
| 10/31/2011 | 07/31/2011 | 04/30/2011 | 01/31/2011 | 10/31/2010 | |
|---|---|---|---|---|---|
| Net Income | 74.10% | 67.15% | 54.88% | -99.43% | -293.03% |
| Total Depreciation and Amortization | -63.16% | -81.08% | -80.88% | -34.88% | -71.21% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.81% | -- | -- | -- | 1,441.18% |
| Change in Net Operating Assets | 141.98% | -52.60% | -86.24% | 149.24% | -243.05% |
| Cash from Operations | 48.13% | 212.50% | -102.27% | 900.00% | -834.23% |
| Capital Expenditure | -- | -- | 98.46% | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 98.46% | -- | -100.00% |
| Total Debt Issued | -49.76% | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -49.76% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -94.12% | 212.50% | -670.00% | 211.11% | 157.95% |
